- Home
- ONON vs PODD Comparison
ONON vs PODD Comparison
Compare ONON & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONON
- PODD
- Stock Information
- Founded
- ONON 2010
- PODD 2000
- Country
- ONON Switzerland
- PODD United States
- Employees
- ONON N/A
- PODD N/A
- Industry
- ONON Shoe Manufacturing
- PODD Medical/Dental Instruments
- Sector
- ONON Consumer Discretionary
- PODD Health Care
- Exchange
- ONON Nasdaq
- PODD Nasdaq
- Market Cap
- ONON 19.5B
- PODD 16.5B
- IPO Year
- ONON 2021
- PODD 2007
- Fundamental
- Price
- ONON $48.43
- PODD $282.80
- Analyst Decision
- ONON Buy
- PODD Buy
- Analyst Count
- ONON 25
- PODD 16
- Target Price
- ONON $57.04
- PODD $291.81
- AVG Volume (30 Days)
- ONON 4.3M
- PODD 574.3K
- Earning Date
- ONON 03-04-2025
- PODD 02-20-2025
- Dividend Yield
- ONON N/A
- PODD N/A
- EPS Growth
- ONON 55.69
- PODD 96.40
- EPS
- ONON 0.46
- PODD 5.78
- Revenue
- ONON $2,555,669,993.00
- PODD $2,071,600,000.00
- Revenue This Year
- ONON $31.74
- PODD $23.56
- Revenue Next Year
- ONON $27.95
- PODD $18.07
- P/E Ratio
- ONON $106.05
- PODD $48.93
- Revenue Growth
- ONON 26.12
- PODD 22.07
- 52 Week Low
- ONON $27.37
- PODD $160.19
- 52 Week High
- ONON $64.05
- PODD $289.46
- Technical
- Relative Strength Index (RSI)
- ONON 28.84
- PODD 54.94
- Support Level
- ONON $50.61
- PODD $270.00
- Resistance Level
- ONON $53.57
- PODD $288.95
- Average True Range (ATR)
- ONON 2.51
- PODD 6.83
- MACD
- ONON -0.98
- PODD -0.31
- Stochastic Oscillator
- ONON 4.41
- PODD 65.78
About ONON On Holding AG
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa, and Asia-Pacific region.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.